Revenue → Gross Profit: $7.09BDiabetes → Revenue: $5.49BGross Profit → Operating cost: $4.59BOperating cost → R&D: $2.52BGross Profit → Operating profit: $2.51BOperating profit → Net Profit: $2.24BOperating cost → Marketing, S&A: $1.95BOncology → Revenue: $1.81BMounjaro → Diabetes: $1.81BRevenue → Cost of Revenue: $1.67BTrulicity → Diabetes: $1.46BVerzenio → Oncology: $1.05BImmunology → Revenue: $0.83BJardiance → Diabetes: $0.69BTaltz → Immunology: $0.60BHumalog → Diabetes: $0.54BZepbound → Diabetes: $0.52BNeuroscience → Revenue: $0.39BOperating profit → Taxes: $0.29BOther oncology → Oncology: $0.27BOther → Revenue: $0.24BCyramza → Oncology: $0.23BEmgality → Neuroscience: $0.23BOlumiant → Immunology: $0.22BHumulin → Diabetes: $0.21BOther neuroscience → Neuroscience: $0.16BBasaglar → Diabetes: $0.16BErbitux → Oncology: $0.14BCialis → Other: $0.14BOther diabetes → Diabetes: $0.12BTyvyt → Oncology: $0.12BOperating cost → Acquired IPR&D: $0.11BForteo → Other: $0.06BOthers → Other: $0.04BOther income → Operating profit: $0.03BOther immunology → Immunology: $0.01BRevenue: $8.77BGross Profit: $7.09BOperating profit: $2.54BOperating cost: $4.59BNet Profit: $2.24BTaxes: $0.29BOther income: $0.03BCost of Revenue: $1.67BMarketing, S&A: $1.95BAcquired IPR&D: $0.11BR&D: $2.52BMounjaro: $1.81BDiabetes: $5.49BTrulicity: $1.46BJardiance: $0.69BHumalog: $0.54BZepbound: $0.52BHumulin: $0.21BBasaglar: $0.16BOther diabetes: $0.12BVerzenio: $1.05BOncology: $1.81BCyramza: $0.23BErbitux: $0.14BTyvyt: $0.12BOther oncology: $0.27BTaltz: $0.60BImmunology: $0.83BOlumiant: $0.22BOther immunology: $0.01BEmgality: $0.23BNeuroscience: $0.39BOther neuroscience: $0.16BCialis: $0.14BOther: $0.24BForteo: $0.06BOthers: $0.04Bcreated with SankeyArt.comRevenue$8.77B26% Y/YGross Profit$7.09B33% Y/YOperating profit$2.54B66% Y/YOperating cost$4.59B19% Y/YNet Profit$2.24B67% Y/YTaxes$0.29B59% Y/YOther income$0.03BCost of Revenue$1.67B3% Y/YMarketing, S&A$1.95B12% Y/YAcquired IPR&D$0.11B5% Y/YR&D$2.52B27% Y/YMounjaro$1.81BDiabetes$5.49B31% Y/YTrulicity$1.46BJardiance$0.69BHumalog$0.54BZepbound$0.52BHumulin$0.21BBasaglar$0.16BOther diabetes$0.12BVerzenio$1.05BOncology$1.81B33% Y/YCyramza$0.23BErbitux$0.14BTyvyt$0.12BOther oncology$0.27BTaltz$0.60BImmunology$0.83B7% Y/YOlumiant$0.22BOther immunology$0.01BEmgality$0.23BNeuroscience$0.39B8% Y/YOther neuroscience$0.16BCialis$0.14BOther$0.24B-12% Y/YForteo$0.06BOthers$0.04BEli Lilly Q1 FY24 Income Statement
2024
Q1 Q2 Q3
Copy and edit diagram